PDCD1 and small cell lung carcinoma: The two main groups of agents used almost exclusively in tumors [31,32] are programmed cell death protein 1 (PD-1) and programmed death-ligand 1 (PD-L1) inhibitors; some authors analyzed the results of these ligands in small cell lung cancer [33,34,35].